TY - JOUR AU - Heyder, Nicolas AU - Kleinau, Gunnar AU - Szczepek, Michal AU - Kwiatkowski, Dennis AU - Speck, David AU - Soletto, Lucia AU - Cerdá-Reverter, José Miguel AU - Krude, Heiko AU - Kühnen, Peter AU - Biebermann, Heike AU - Scheerer, Patrick PY - 2019 M3 - Original Research TI - Signal Transduction and Pathogenic Modifications at the Melanocortin-4 Receptor: A Structural Perspective JO - Frontiers in Endocrinology UR - https://www.frontiersin.org/articles/10.3389/fendo.2019.00515 VL - 10 SN - 1664-2392 N2 - The melanocortin-4 receptor (MC4R) can be endogenously activated by binding of melanocyte-stimulating hormones (MSH), which mediates anorexigenic effects. In contrast, the agouti-related peptide (AgRP) acts as an endogenous inverse agonist and suppresses ligand-independent basal signaling activity (orexigenic effects). Binding of ligands to MC4R leads to the activation of different G-protein subtypes or arrestin and concomitant signaling pathways. This receptor is a key protein in the hypothalamic regulation of food intake and energy expenditure and naturally-occurring inactivating MC4R variants are the most frequent cause of monogenic obesity. In general, obesity is a growing problem on a global scale and is of social, medical, and economic relevance. A significant goal is to develop optimized pharmacological tools targeting MC4R without adverse effects. To date, this has not been achieved because of inter alia non-selective ligands across the five functionally different MCR subtypes (MC1-5R). This motivates further investigation of (i) the three-dimensional MC4R structure, (ii) binding mechanisms of various ligands, and (iii) the molecular transfer process of signal transduction, with the aim of understanding how structural features are linked with functional-physiological aspects. Unfortunately, experimentally elucidated structural information is not yet available for the MC receptors, a group of class A G-protein coupled receptors (GPCRs). We, therefore, generated MC4R homology models and complexes with interacting partners to describe approximate structural properties associated with signaling mechanisms. In addition, molecular insights from pathogenic mutations were incorporated to discriminate more precisely their individual malfunction of the signal transfer mechanism. ER -